ALLIANCE AMBULATORY INFUSION CENTER  
Promoting Wellness One Community at a Time
   
  HomeClinicsPharmacyReferral Forms.    Contact Us   
   

 

New Medications

Synagis®

Synagis® (palivizumab) is the first monoclonal antibody successfully developed to combat an infectious disease. It is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease.

Rheumatoid® Arthritis
REMICADE
®, in combination with methotrexate, is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active rheumatoid arthritis.

Crohn's Disease
REMICADE
® is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy.

IVIG
IVIG is a solution of globulins containing antibodies normally present in adult human blood. Globulins are simple proteins that provide immunity against disease. A protein is made up of several amino acids, which are the microscopic building blocks that make up all cells. Many globulins are inherited, so that the body is able from birth to fight off bacteria and other infections. IVIG is used for maintenance treatment of people who are unable to produce sufficient amounts of immune globulin antibodies. Children who are HIV+ have impaired primary and secondary responses to infection. IVIG can help prevent or treat infections such as meningitis, bacteremia, osteomyelitis, septic arthritis, acute sinusitis, pneumonia, acute mastoiditis, or abscess of an internal organ.

Xolair®
Xolair® is a different kind of allergic asthma medication. It's the first asthma treatment that works by blocking immunoglobulin E (IgE), an underlying cause of allergic asthma symptoms. Allergic asthma is triggered by year-round allergens in the air and is a common form of the disease. The National Institutes of Health estimates that 60% of the people in the United States with asthma have allergic asthma. Xolair® treats allergic asthma in a way that is different from other medications. If you're taking inhaled steroids yet continue to have asthma attacks and symptoms, Xolair ®may be able to help.

 

 

 

        © Copyright 2005 Mission Web Design